Profil
Dr. Dolores J.
Schendel is a Chief Scientific Officer at MediGene AG and a Chief Executive Officer at Medigene, Inc. Dr. Schendel was previously employed as a Managing Director by Medigene Immunotherapies GmbH, a Member-Scientific Review Board by Deutsche Forschungsgemeinschaft, a Member-Scientific Review Board by European Research Council, a Member-Scientific Review Board by German Cancer Aid, and a Professor by Ludwig-Maximilians-Universität München.
She also served on the board at Institute of Molecular Immunology.
She received her doctorate degree from the University of Wisconsin.
Aktiva positioner av Dolores Schendel
| Företag | Position | Start |
|---|---|---|
| MEDIGENE AG | Teknisk/Vetenskaplig/F&U Direktör | 2014-05-01 |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Verkställande Direktör | - |
Tidigare kända positioner av Dolores Schendel
| Företag | Position | Slut |
|---|---|---|
Institute of Molecular Immunology | Direktör/Styrelseledamot | 2013-01-01 |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Företagsledare/Principal | - |
German Cancer Aid | Företagsledare/Principal | - |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Verkställande Direktör | - |
Dolores Schendels utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
MediGene AG
MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies | Health Technology |
MediGene, Inc.
MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars | Miscellaneous |
Deutsche Forschungsgemeinschaft
Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute of Molecular Immunology | |
Medigene Immunotherapies GmbH
Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer | Health Technology |
German Cancer Aid |
















